Food & Food Contact Materials
CIRS Group
Chemicals
Cosmetic
Food
Medical Devices
Agrochemicals
CIRS Testing
Carbon Neutrality
Search
Q&A
FAQs on the Replacement of Health Food Registration Certificate in China (Vol. 4)
FAQs on the Replacement of Health Food Registration Certificate in China (Vol. 3)
FAQs on the Replacement of Health Food Registration Certificate in China (Vol. 2)
On April 25, 2025, we hosted a free Chinese webinar on the key points and considerations in food registration in different countries and US food label compliance. Many questions were raised during the webinar.We have collected the questions and made a Q&A summary.
On April 23, the State Administration for Market Regulation (SAMR) of China issued the Q&A on the Registration of Foods for Special Medical Purposes Infant Formula under the New National Standard (hereinafter referred to as the “Q&A”). The purpose of the Q&A is to facilitate the re-registration process following the promulgation of the National Food Safety Standard - General Rules for Food for Special Medical Purpose Infant Formula (GB 25596—2025) (hereinafter referred to as the “New National Standard”), guide enterprises in the standardized submission of applications, and ensure a smooth market transition.
We have collected frequently asked questions on the dietary supplement in the United States for your reference.
Based on our years' of experience, we have collected frequently asked questions on health food/dietary supplements registration in China and translated them into English for your reference.
We have collected frequently asked questions on the dietary supplement in the United States for your reference.
A great many holders of registration certificates, especially those registered under the previous Ministry of Health (MOH) should redo or supplement the function tests to obtain a new certificate within a 5-year transitional period. To help clients better comply with the regulation, we have collected frequently asked questions on the change of health food registration in China for your reference.
On December 5, 2024, CFE published eighteen frequently asked questions related to formulas for special medical purpose (FSMP), the contents covering formulas, labels and instructions for use, production process, quality and safety, clinical trail, etc.